A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

Local Institution - 0001, Randwick

Local Institution - 0002, Parkville

Local Institution, South Brisbane

Local Institution - 0003, Perth

Local Institution - 0016, Marseille

Local Institution - 0027, Milan

Local Institution - 0038, Hamburg

Local Institution - 0009, Madrid

Local Institution - 0059, Seville

Local Institution - 0028, Valencia

Local Institution - 0011, St Louis

Local Institution - 0039, Tübingen

Local Institution - 0029, Little Rock

Local Institution - 0015, Paris

Local Institution - 0013, Villejuif

Local Institution - 0037, Würzburg

Local Institution - 0014, Lyon

Local Institution - 0008, Barcelona